TipRanks
Go Ultimate55% OFF

Travere Therapeutics (17R) Cash flow

Travere Therapeutics Cash Flow

CH:17R's free cash flow for Q2 2026 was $58.07M. For the 2026 fiscal year, CH:17R's free cash flow was increased by $0.00 and operating cash flow was $58.07M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 37.78M$ -237.47M$ -280.02M$ -186.29M$ -14.79M
$ 27.89M$ 99.33M$ 55.78M$ -32.55M$ -137.62M
$ -33.47M$ 139.42M$ 218.75M$ 117.57M$ 231.68M
$ 93.03M$ 58.53M$ 58.18M$ 61.69M$ 165.75M
$ 37.78M$ -338.69M$ -321.61M$ -214.66M$ -38.94M

Currency in USD

Travere Therapeutics Cash Flow

-400M-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing